Boston, United States
QSimulate, founded in 2018, is making waves in the Pharmaceutical industry by providing quantum-powered simulation solutions aimed at reshaping computational drug discovery. Their offerings promise to significantly reduce R&D timelines while enhancing the success rates of therapeutic candidates.
With offices strategically spread across Boston, MA, Berkeley, CA, Ghent, Belgium, and Tokyo, Japan, QSimulate maintains a strong global presence, allowing them to tap into diverse markets and ecosystems for drug discovery.
Recently, QSimulate secured a $2.50M Venture Round investment on November 27, 2023. This funding round was backed by prominent investors, including UTokyo Innovation Platform, 2xN, and Kyoto University Innovation Capital Co., Ltd, marking a vote of confidence in their technological advancements and market potential.
Overall, QSimulate stands out as an innovative player with significant growth prospects, poised to disrupt traditional drug discovery methods.
